

Abaloparatide approved
'Bone Up' por Dr Richie Abel (PhD) and Prof David Armstrong (MD)
T3 · E2
2 sept 2024
11:35
Notas del episodio
The lads talked to each other about the exciting news that the National Institute for Health and Care Excellence (Nice) announced it had approved a new drug, Abaloparatide, for use by the health service. It will be available for use on the NHS in England within three months.
Palabras clave
osteoporosis
fracture risk
bone
imminent fracture
fracture liason service
fracture
hip fracture
fragility fractures